Company

About

CartilaGen

CartilaGen

Iowa City, Iowa, United States

CartilaGen Inc. is developing an intra-articular injection of a small-molecule drug capable of preventing post-traumatic osteoarthritis. CartilaGen's solution aims to provide an unprecedented disease-modifying treatment to an area of medicine that remains an unmet medical need.

Emmyon

Emmyon

Coralville, Iowa, United States

Emmyon - Discovery and development of small molecules that improve muscle mass, strength and metabolism Commercialization of small molecules through licensing agreements and partnerships with consumer-facing companies Funded by private investors and the National Institutes of Health

Proliant Health & Biologicals

Proliant Health & Biologicals

2425 SE Oak Tree Ct, Ankeny, Iowa 50021, US

Proliant Health & Biologicals is focused on improving worldwide health through the development of clinically safe biotherapeutics to address unmet needs in gastroenterology, oncology, and infectious disease management. Our passion is to help people thrive through healthier living. Our motivation for conducting basic research, clinical studies, and appropriately educating patients and healthcare providers is driven to meet this goal. PHB has manufacturing and basic research facilities in Boone, Iowa as well as Fielding, New Zealand.

Steel Therapeutics, Inc.

Steel Therapeutics, Inc.

iowa city, iowa, united states

Steel Therapeutics is an Iowa-based pharmaceutical company focused on increasing access to life-changing therapies that have a track record of efficacy from compounding pharmacies.

VIDA

VIDA

2500 Crosspark Road, W250 BioVentures Center, Coralville, Iowa 52241, US

VIDA is a clinical imaging intelligence company that is accelerating the approval and adoption of life-saving therapies to patients through an AI-powered digital biomarker solution. With proprietary imaging biomarkers for precise quantitative endpoints and a trial imaging management solution, VIDA's solution is helping biopharma sponsors save millions in drug development costs.